Differences between GABA levels in Alzheimer's disease and Down syndrome with Alzheimer-like neuropathology

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 363, Issue 2, 2001, Pages 139-145

  Seidl, Rainer ^a   Cairns, Nigel ^b   Singewald, Nicolas ^c   Kaehler, Stefan T ^c   Lubec, Gert ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Alzheimer's disease; Amino acid neurotransmitters; Down syndrome; GABA; Glutamate

Indexed keywords

4 AMINOBUTYRIC ACID; ARGININE; ASPARTIC ACID; GLUTAMIC ACID; GLUTAMINE; GLYCINE; SERINE; TAURINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CAUDATE NUCLEUS; CEREBELLUM; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; MENTAL DEFICIENCY; NERVE DEGENERATION; NEUROPATHOLOGY; OCCIPITAL CORTEX; TEMPORAL LOBE; THALAMUS; TISSUE LEVEL;

ADULT; AGED; ALZHEIMER DISEASE; AMINO ACIDS; BRAIN; DOWN SYNDROME; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HUMANS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 0035095970     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002100000346     Document Type: Article

References (39)

1. Correlation between the morphology of diffuse and primitive beta-amyloid (A-beta) deposits and the frequency of associated cells in Down's syndrome
2. Growth and development of the brain in Down syndrome
3. Neuropathology
4. First one in, last one out: The role of gabaergic transmission in generation and degeneration
5. A postmortem study of amino acid neurotransmitters in Alzheimer's disease
6. Down syndrome (trisomy 21)
7. Glutamate: A neurotransmitter in mammalian brain
8. Treatment of functional decline in adults with Down syndrome using selective serotonin-reuptake inhibitor drugs
9. Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue
10. A disorder of cortical GABAergic innervation in Alzheimer's disease
11. Neuropsychological evaluation of adults with Down's syndrome: Patterns of selective impairment in nonde-mented old adults
12. Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease
13. Decrease of heart protein kinase C and cyclin-dependent kinase precedes death in perinatal asphyxia of the rat
14. Neurotransmitter deficits in Alzheimer's disease and in other dementing disorders
15. Some morphological observations on the brains of patients with Down's syndrome: Their relationship to age and dementia
16. The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardisation of the neuropathological assessment of Alzheimer's disease
17. Immunohistochemical study of GABA(A) receptor beta2/3 subunits in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes
18. GABA-agonist therapy for Alzheimer's disease
19. Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia
20. Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?
21. Postmortem changes of amino compounds in human and rat brain
22. Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease
23. Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease
24. The neurochemical pathology of Alzheimer's disease
25. A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease
26. Amino acid neurotransmitter deficits in adult Down's syndrome brain tissue
27. Excitatory amino acids and monoamines in parahippocampal gyrus and frontal cortical pole of adults with Down syndrome
28. A post-mortem study of the cholinergic and GABA systems in senile dementia
29. Serotonin (5-HT) in brains of adult patients with Down syndrome
30. Loss of cortical GABA uptake sites in Alzheimer's disease
31. In vivo release patterns and cardiovascular properties of inhibitory and excitatory amino acids in the hypothalamus
32. Imaging of the serotonergic system: Interactions of neuroanatomical and functional abnormalities of depression
33. The NINCDA-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease
34. Major depression in Down's syndrome
35. Abnormal neurogenesis and synaptogenesis in Down syndrome brain
36. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down syndrome
37. Alzheimer-like cholinergic deficiency in Down syndrome
38. Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome
39. Regional brain 5-hydroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease